首页|期刊导航|中国医药科学|基于网络药理学青红活血汤治疗慢性萎缩性胃炎的机制研究

基于网络药理学青红活血汤治疗慢性萎缩性胃炎的机制研究OA

Mechanism study of Qinghong Huoxue Decoction for the treatment of chronic atrophic gastritis based on network pharmacology

中文摘要英文摘要

目的 研究胡斌名老中医治疗慢性萎缩性胃炎经验方青红活血汤治疗慢性萎缩性胃炎的网络药理学机制.方法 通过数据库对青红活血汤潜在靶标预测,对慢性萎缩性胃炎的靶点筛选,构建数据库绘制蛋白质相互作用(PPI)网络及拓扑网络并进行富集分析.结果 基于中药系统药理学数据库与分析平台(TCMSP)数据库,检索到鸡血藤、薏苡仁、厚朴、香橼、太子参的化合物分别为 68、38、139、47 和 25 个;基于文献检索三叶青、红藤、香茶菜的化合物分别为 86、110 和 29 个.根据设置的筛选条件生物利用度≥30%、类药性≥0.18,共筛选出 71 个化合物.通过基因数据库(GeneCards)筛选出与慢性萎缩性胃炎相关的靶点共有 732 个.通过维恩(Venn)在线分析平台构建药物靶点与慢性萎缩性胃炎靶点映射关系图,共得到129 个青红活血汤治疗慢性萎缩性胃炎的靶点.基因本体分析显示,青红活血汤治疗慢性萎缩性胃炎作用机制可能与miRNA成熟的负调控、RNA聚合酶Ⅱ启动子的转录正调控参与细胞对化学刺激的反应、细胞凋亡机制等有关.代谢通路(Pathway)分析显示,青红活血汤治疗慢性萎缩性胃炎的主要通路有脂质与动脉粥样硬化、麻疹、缺氧诱导因子-1(HIF-1)信号通路、晚期糖基化终末产物与糖基化终末产物受体信号通路(AGE-RAGE)在糖尿病并发症中的作用等.结论 青红活血汤对慢性萎缩性胃炎的治疗可能与miRNA成熟的负调控、RNA聚合酶Ⅱ启动子的转录正调控参与细胞对化学刺激的反应、细胞凋亡机制等有关,主要通路有脂质与动脉粥样硬化、麻疹、HIF-1 信号通路、AGE-RAGE信号通路在糖尿病并发症中的作用等.

Objective To investigate the network pharmacological mechanism of Qinghong Huoxue Decoction,an experienced prescription developed by Hu Bin,a renowned Chinese medicine practitioner,for the treatment of chronic atrophic gastritis.Methods Potential targets of Qinghong Huoxue Decoction were predicted and targets associated with chronic atrophic gastritis were screened using a database.The database was constructed to map the protein-protein interaction network and the topological network,followed by enrichment analysis.Results Based on the Traditional Chinese Medicine System Pharmacology Database and Analysis Platform,compounds were retrieved as follows:68 for chicken blood vine,38 for coix seed,139 for Magnolia officinalis,47 for citron,and 25 for Pseudostellaria heterophylla.Additionally,literature searches identified 86 compounds for radix tetrastigme,110 for Sargent gloryvine,and 29 for Isodon amethystoides.A total of 71 compounds were screened based on the set screening conditions of oral bioavailability≥30%and drug like≥0.18.732 targets related to chronic atrophic gastritis were screened using GeneCards.The mapping relationship between drug targets and chronic atrophic gastritis targets was constructed using the Venn online analysis platform,resulting in 129 targets identified for the treatment of chronic atrophic gastritis with Qinghong Huoxue Decoction.Gene ontology analysis indicated that the mechanism of action of Qinghong Huoxue Decoction for the treatment of chronic atrophic gastritis seemed to be related to the negative regulation of miRNA maturation,positive transcriptional regulation of the RNA polymeraseⅡpromoter involved in cellular response to chemical stimuli,and the mechanism of cell apoptosis,etc.Pathway analysis revealed that the primary pathways affected by Qinghong Huoxue Decoction in the treatment of chronic atrophic gastritis included lipid and atherosclerosis,measles,hypoxia-inducible factor-1(HIF-1)signaling pathways,and advanced glycosylation end products and their receptor(AGE-RAGE)signaling pathway in diabetic complications.Conclusion The treatment of chronic atrophic gastritis with Qinghong Huoxue Decoction may be associated with the negative regulation of miRNA maturation,positive transcriptional regulation of the RNA polymerase Ⅱ promoter involved in cellular responses to chemical stimuli,and the mechanism of cell apoptosis,etc.The primary pathways identified include lipid and atherosclerosis,measles,HIF-1 signaling pathways,and the AGE-RAGE signaling pathway in diabetic complications.

李海涛;张晓明;郭婷婷

浙江中医药大学附属金华市中医院脾胃病科,浙江 金华 321017浙江中医药大学附属金华市中医院脾胃病科,浙江 金华 321017浙江中医药大学附属金华市中医院脾胃病科,浙江 金华 321017

医药卫生

慢性萎缩性胃炎青红活血汤网络药理学作用机制

Chronic atrophic gastritisQinghong Huoxue DecoctionNetwork pharmacologyMechanism of action

《中国医药科学》 2025 (9)

56-59,167,5

浙江省中青年临床名中医培养项目(浙中医药函[2021]9号)浙江中医药大学附属医院科研项目(2021FSYYZY29).

10.20116/j.issn2095-0616.2025.09.13

评论